Nonadherence and uncontrolled arterial hypertension in Croatia—Insights from the May Measurement Month 2023 campaign and Hunting the silent killer programme
Open Access
- 16 October 2025
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
Abstract
Aims: To determine the prevalence of non‐adherence to antihypertensive medicines and to identify demographic and behavioral factors associated with non‐adherence in subjects enrolled in the May Measurement Month (MMM) 2023, as part of the permanent public health action Hunting the silent killer.Methods: In this cross‐sectional opportunistic screening, the original MMM questionnaire was extended by adding questions related to salt intake, mobile phones, and adherence, which was assessed using the validated 5‐item Medication Adherence Report Scale (scores ≥23 indicating adherence). Out of 10 488 subjects enrolled in MMM 2023 in Croatia, this analysis included 8739 subjects who were enrolled in 329 community pharmacies and had three BP measurements using the same device.Results: Among 4964 HT participants, 68.2% were adherent. Non‐adherence was more common among men, urban residents, and younger individuals. Female sex (OR = 1.29) and rural residence (OR = 1.21) were associated with higher adherence. Non‐adherence was significantly associated with poorer BP control (p < 0.05). Forgetfulness and missing doses were the most frequently reported behaviors.Conclusion: Nearly one‐third of HT patients in Croatia are nonadherent to prescribed medicines, contributing to suboptimal BP control. Routine adherence screening and tailored interventions, particularly for younger men and urban dwellers, are urgently needed to improve cardio‐kidney‐metabolic outcomes.Keywords
This publication has 24 references indexed in Scilit:
- Patient perceptions, motivations and barriers to treatment adherence in hypertension: results of a questionnaire-based survey in five European countriesBlood Pressure, 2025
- Leveraging digital medication adherence technologies to enhance sustainability of European health systems: ENABLE’s key recommendationsThe Lancet Regional Health - Europe, 2024
- Improving blood pressure and dyslipidemia control by increasing health literacy in Croatia-missions 70/26 & Do you know what is your numberBlood Pressure, 2024
- Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021The Lancet, 2024
- Medical Measures in Hypertensives Considered ResistantAmerican Journal of Hypertension, 2023
- The role of adherence in patients with chronic diseasesEuropean Journal of Internal Medicine, 2023
- Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017The Lancet, 2018
- FIXED-DOSE COMBINATION THERAPY DECREASED PREVALENCE OF MASKED UNCONTROLLED HYPERTENSION (MUCH) IN VERY HIGH RISK PATIENTSJournal Of Hypertension, 2018
- PHARMACIST INTERVENTION IN HYPERTENSION. PHYSICIAN-PHARMACIST COLLABORATIVE PROJECT OF THE CROATIAN SOCIETY OF HYPERTENSION (PHY-PHA-COLL-CRO).Journal Of Hypertension, 2018
- Drug adherence in hypertensionPharmacological Research, 2017